Anticipation and consumption of food each increase the concentration of neuroactive steroids in rat brain and plasma

Pharmacology Biochemistry and Behavior

Volumn 85, Issue 1, 2006, Pages 76-81

  Pisu, Maria Giuseppina ^a   Floris, Ivan ^b   Maciocco, Elisabetta ^a   Serra, Mariangela ^a,b   Biggio, Giovanni ^a,b  

^a CNR   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Abecarnil; Food intake; Neuroactive steroid; Rat

Indexed keywords

3ALPHA HYDROXY 5 ALPHA PREGNAN 20 ONE; 3ALPHA,21 DIHYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; ABECARNIL; NEUROSTEROID; PROGESTERONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTICIPATION; ARTICLE; BRAIN CORTEX; BRAIN FUNCTION; BRAIN REGION; EMOTION; FOOD INTAKE; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; STEROID BLOOD LEVEL;

ANIMALS; BRAIN; FEEDING BEHAVIOR; MALE; RATS; RATS, SPRAGUE-DAWLEY; STEROIDS;

EID: 33751105243     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2006.07.011     Document Type: Article

References (52)

1. 2 inhalation. Eur J Pharmacol 261 (1994) 317-320
2. Barbaccia M.L., Roscetti G., Bolacchi F., Concas A., Mostallino M.C., Purdy R.H., et al. Stress-induced increase in brain neuroactive steroids: antagonism by abecarnil. Pharmacol Biochem Behav 54 (1996) 205-210
3. A receptor function after acute stress. Neuroendocrinology 63 (1996) 166-172
4. Barbaccia M.L., Roscetti G., Trabucchi M., Purdy R.H., Mostallino M.C., Concas A., et al. The effects of inhibitors of GABAergic transmission and stress on brain and plasma allopregnanolone concentrations. Br J Pharmacol 120 (1997) 1582-1588
5. Barbaccia M.L., Affricano D., Purdy R.H., Maciocco E., Spiga F., and Biggio G. Clozapine, but not haloperidol, increases brain concentrations of neuroactive steroids in the rat. Neuropsychopharmacology 25 4 (2001) 489-497
6. A receptor. Nat Rev Neurosci 6 (2005) 565-575
7. Belelli D., Bolger M.B., and Gee K.W. Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Eur J Pharmacol 166 (1989) 325-329
8. In: Biggio G., and Purdy R.H. (Eds). Neurosteroids and brain function. International review of neurobiology vol. 46 (2001), Academic Press, San Diego
9. Biggio G., Fadda F., Fanni P., Tagliamonte A., and Gessa G.L. Rapid depletion of serum tryptophan, brain tryptophan, serotonin and 5-hydroxyindolacetic acid by a tryptophan-free diet. Life Sci 14 (1974) 1321-1329
10. Biggio G., Concas A., Corda M.G., Giorgi O., Sanna E., and Serra M. GABAergic and dopaminergic transmission in the rat cerebral cortex: effect of stress, anxiolytic and anxiogenic drugs. Pharmacol Ther 48 (1990) 121-142
11. Bitran D., Hilvers R.J., and Kellogg C.K. Anxiolytic effects of 3α-hydroxy-5α[β]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor. Brain Res 561 (1991) 157-161
12. Calogero A.E., Gallucci W.T., Chrousos G.P., and Gold P.W. Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin-releasing hormone secretion in vitro. Brain Res 463 (1988) 28-36
13. Concas A., Mostallino M.C., Perra C., Lener R., Roscetti G., Barbaccia M.L., et al. Role of brain allopregnanolone in the plasticity of γ-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery. Proc Natl Acad Sci U S A 95 (1998) 13284-13289
14. Cooper S.J., and Higgs S. Benzodiazepine receptors and the determination of palatability. In: Cooper S.J., and Clifton P.G. (Eds). Drug receptor subtypes and ingestive behavior (1996), Academic Press, London 347-368
15. A receptor modulators. J Pharmacol Exp Ther 273 (1995) 241-247
16. Finlay J.M., Zigmond M.J., and Abercrombie E.D. Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam. Neuroscience 64 (1995) 619-628
17. Finn D.A., Ford M.M., Wiren K.M., Roselli C.E., and Crabbe J.C. The role of pregnane neurosteroids in ethanol withdrawal: behavioral genetic approaches. Pharmacol Ther 101 (2004) 91-112
18. A receptor expression and function during progesterone treatment and withdrawal. Mol Pharmacol 57 (2000) 1262-1270
19. A receptor γ2 subunit gene expression induced by long-term administration of oral contraceptives in rats. Neuropharmacology 42 (2002) 325-336
20. Ghiani C.A., Dazzi L., Maciocco E., Flore G., Maira G., and Biggio G. Antagonism by abecarnil of enhanced acetylcholine release in the rat brain during anticipation but not consumption of food. Pharmacol Biochem Behav 59 (1998) 657-662
21. A receptor subunits: plasticity of expression during the estrous cycle. Neuroscience 136 (2005) 457-466
22. Higgs S., and Cooper S.J. Antineophobic effect of the neuroactive steroid 3α-hydroxy-5β-pregnan-20-one in male rats. Pharmacol Biochem Behav 60 (1998) 125-131
23. Holmes M.M., and Mistlberger R.E. Food anticipatory activity and photic entrainment in food-restricted BALB/c mice. Physiol Behav 68 (2000) 655-666
24. Horger B.A., and Roth R.H. The role of mesoprefrontal dopamine neurons in stress. Crit Rev Neurobiol 10 (1996) 395-418
25. Inglis F.M., Day J.C., and Fibiger H.C. Enhanced acetylcholine release in hippocampus and cortex during the anticipation and consumption of a palatable meal. Neuroscience 62 (1994) 1049-1056
26. Kokate T.G., Banks M.K., Magee T., Yamaguchi S., and Rogawski M.A. Finasteride, a 5α-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice. J Pharmacol Exp Ther 288 (1999) 679-684
27. A receptors. Prog Neurobiol 71 (2003) 67-80
28. A receptor subunit expression in the midbrain during the oestrous cycle in Wistar rats. Neuroscience 131 (2005) 397-405
29. A receptors mediating tonic inhibition alter seizure susceptibility and anxiety. Nat Neurosci 8 (2005) 797-804
30. A receptor. Mechanism of action and physiological significance. Prog Neurobiol 38 (1992) 379-395
31. Marx C.E., VanDoren M.J., Duncan G.E., Lieberman J.A., and Morrow A.L. Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents. Neuropsychopharmacology 28 (2003) 1-13
32. Mendelson W.B., Martin J.V., Perlis M., Wagner R., Majewska M.D., and Paul S.M. Sleep induction by an adrenal steroid in the rat. Psychopharmacology 93 (1987) 226-229
33. Merali Z., McIntosh J., and Anisman H. Anticipatory cues differentially provoke in vivo peptidergic and monoaminergic release at the medial prefrontal cortex. Neuropsychopharmacology 29 (2004) 1409-1418
34. Monteleone P., Luisi S., Tonetti A., Bernardi F., Genazzani A.D., Luisi M., et al. Allopregnanolone concentrations and premenstrual syndrome. Eur J Endocrinol 142 (2000) 269-273
35. Pisu M.G., and Serra M. Neurosteroids and neuroactive drugs in mental disorders. Life Sci 74 (2004) 181-197
36. Purdy R.H., Morrow A.L., Blinn J.R., and Paul S.M. Synthesis, metabolism, and pharmacological activity of 3 alpha-hydroxy steroids which potentiate GABA-receptor-mediated chloride ion uptake in rat cerebral cortical synaptoneurosomes. J Med Chem 33 (1990) 1572-1581
37. Purdy R.H., Morrow A.L., Moore Jr. P.H., and Paul S.M. Stress-induced elevations of γ-aminobutyric acid type A receptor-active steroids in the rat brain. Proc Natl Acad Sci U S A 88 (1991) 4553-4557
38. Rapkin A.J., Morgan M., Goldman L., Brann D.W., Simone D., and Mahesh V.B. Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet Gynecol 90 (1997) 709-714
39. Rasgon N., Serra M., Biggio G., Pisu M.G., Fairbanks L., Tanavoli S., et al. Neuroactive steroid-serotonergic interaction: responses to an intravenous l-tryptophan challenge in women with premenstrual syndrome. Eur J Endocrinol 145 (2001) 25-33
40. Reddy D.S. Role of neurosteroids in catamenial epilepsy. Epilepsy Res 62 (2004) 99-118
41. Reddy D.S., and Kulkarni S.K. The role of GABAA and mitochondrial diazepam-binding inhibitor receptors on the effects of neurosteroids on food intake in mice. Psychopharmacology 137 (1998) 391-400
42. Rueter L.E., Fornal C.A., and Jacobs B.L. A critical review of 5-HT brain microdialysis and behavior. Rev Neurosci 8 (1997) 117-137
43. A receptor activity in rat hippocampus. J Neurosci 24 (2004) 6521-6530
44. Serra M., Littera M., Pisu M.G., Muggironi M., Purdy R.H., and Biggio G. Steroidogenesis in rat brain induced by short-and long-term administration of carbamazepine. Neuropharmacology 39 (2000) 2448-2456
45. A receptor function in rat brain. J Neurochem 75 (2000) 732-740
46. Serra M., Pisu M.G., Muggironi M., Parodo V., Papi G., Sari R., et al. Opposite effects of short-versus long-term administration of fluoxetine on the concentrations of neuroactive steroids in rat plasma and brain. Psychopharmacology 158 (2001) 48-54
47. A receptor. Methods and new frontiers in neuroscience vol. 22 (2003), CRC Press 143-172
48. A receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 392 (1998) 926-930
49. Stephens D.N., Turski L., Jones G.H., Steppuhn K.G., and Schneider H.H. Abecarnil: a novel anxiolytic with mixed full agonist/partial agonist properties in animal models of anxiety and sedation. Psychopharmacology 11 (1993) 79-95
50. Toufexis D.J., Davis C., Hammond A., and Davis M. Progesterone attenuates corticotropin-releasing factor-enhanced but not fear-potentiated startle via the activity of its neuroactive metabolite, allopregnanolone. J Neurosci 24 (2004) 10280-10287
51. Uzunov D.P., Cooper T.B., Costa E., and Guidotti A. Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proc Natl Acad Sci U S A 93 (1996) 12599-12604
52. Uzunova V., Sheline Y., Davis J.M., Rasmusson A., Uzunov D.P., Costa E., et al. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci U S A 95 (1998) 3239-3244